NewsAvi Kapoor
Galapagos NV
LKFT · NYSE
$31.65+$0.25 (+0.80%)TodayMarket closed ·
Prev close $31.40
Latest news
- Press releaseGlobe Newswire
U.S. FDA Grants Orphan Drug Designation to Gamgertamig for the Treatment of Pemphigus
- Press releasePRNewswire
Keymed Biosciences Announces 2026 H1 Results and Business Updates
- News
Lakefront Biotherapeutics Q2 EPS $0.29 Beats $(13.52) Estimate, Sales $21.624M Beat $7.210M Estimate
- Press releaseGlobe Newswire
Lakefront Biotherapeutics Reports Half-Year 2026 Financial Results and Provides Business Update
- Press releaseGlobe Newswire
Lakefront Announces Initiation of €50 Million Stock Repurchase Program
- Press releaseBusiness Wire
Gilead Sciences and Lakefront Complete Acquisition of Ouro Medicines to Further Expand Inflammation Pipeline
- Press releaseGlobe Newswire
GILEAD SCIENCES AND LAKEFRONT COMPLETE ACQUISITION OF OURO MEDICINES TO FURTHER EXPAND INFLAMMATION PIPELINE
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.